This opportunity uses the R21 Exploratory/Developmental Research Grants funding mechanism.
The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection. Co-infection is defined as the occurrence of infections by two or more infectious (pathogenic or non-pathogenic) agents – either concurrently or sequentially – and includes both acute and chronic infections by viruses, bacteria, parasites, and/or other microorganisms. Preference will be given to investigations of co-infections with known oncogenic agents (excluding human immunodeficiency virus [HIV]) and of co-infections that engender novel opportunities for prevention and treatment.
Funding & Duration
The combined budget for direct costs for the two-year project period may not exceed US $275,000 (approx. AUD $405,000). No more than US $200,000 (approx. AUD $295,000) may be requested in any single year.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Submission Requirements & Due Date
- 10 February 2020: Letter of Intent (LOI) due. Please forward a copy of your LOI to Research Services.
- 10 March 2020: applications submitted for internal review.
- Please email email@example.com if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review